Biohaven Pharmaceutical H... (BHVN)
36.17
0.60 (1.69%)
At close: Jan 15, 2025, 1:40 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 248.40M | 204.88M | 76.06M | 82.51M | 316.73M | 264.25M | 131.47M |
| Short-Term Investments | 133.42M | 260.46M | 192.65M | 223.19M | n/a | n/a | n/a |
| Long-Term Investments | 2.40M | 2.40M | 6.00M | 7.18M | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 2.58M | 3.22M | 1.01M | 7.83M | 11.43M | 7.88M |
| Receivables | 13.65M | 46.14M | 9.91M | n/a | n/a | n/a | n/a |
| Inventory | -396.00K | 56.16M | 6.73M | 39.56M | n/a | n/a | n/a |
| Other Current Assets | 47.38M | 75.49M | 8.86M | 7.25M | 11.55M | 8.09M | 5.20M |
| Total Current Assets | 442.45M | 586.97M | 94.82M | 89.76M | 328.28M | 272.34M | 136.66M |
| Property-Plant & Equipment | 48.58M | 52.44M | 18.23M | 13.56M | 8.15M | 6.25M | 2.34M |
| Goodwill & Intangibles | 19.79M | 19.79M | 19.79M | 39.09M | n/a | n/a | n/a |
| Total Long-Term Assets | 70.77M | 74.81M | 47.24M | 21.74M | 15.98M | 17.67M | 10.22M |
| Total Assets | 513.21M | 661.78M | 142.06M | 111.50M | 344.26M | 290.01M | 146.89M |
| Account Payables | 15.58M | 10.70M | 4.78M | 2.76M | 14.07M | 10.75M | 4.72M |
| Deferred Revenue | n/a | -38.23M | -439.00K | -675.00K | n/a | n/a | n/a |
| Short-Term Debt | 3.31M | 3.02M | n/a | 675.00K | n/a | n/a | n/a |
| Other Current Liabilities | 36.54M | 38.13M | 37.16M | 26.44M | 52.10M | 8.78M | 4.71M |
| Total Current Liabilities | 55.42M | 90.02M | 41.94M | 29.88M | 66.17M | 19.53M | 9.43M |
| Long-Term Debt | 27.57M | 30.58M | 2.80M | 270.39M | n/a | 117.52M | n/a |
| Other Long-Term Liabilities | 2.25M | 2.41M | 2.64M | -265.55M | 285.51M | 2.04M | 5.49M |
| Total Long-Term Liabilities | 29.81M | 32.99M | 5.43M | 4.84M | 285.51M | 119.56M | 5.49M |
| Total Liabilities | 85.24M | 123.01M | 47.37M | 34.72M | 351.69M | 139.09M | 14.92M |
| Total Debt | 30.88M | 30.58M | 626.72M | 267.46M | n/a | 117.52M | n/a |
| Common Stock | 887.53M | 615.74M | 1.68B | 1.25B | 881.43M | 554.38M | 311.06M |
| Retained Earnings | -499.29M | -91.12M | -2.59B | -1.74B | -972.37M | -443.57M | -202.65M |
| Comprehensive Income | -65.00K | 284.00K | -73.00K | 314.00K | n/a | n/a | n/a |
| Shareholders Equity | 427.98M | 538.77M | 34.69M | 16.78M | -7.42M | 150.92M | 131.97M |
| Total Investments | 135.82M | 260.46M | 6.00M | 7.18M | n/a | n/a | n/a |